Premium
COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies
Author(s) -
Declercq Jozefien,
Tobback Els,
Vanhee Stijn,
De Ruyck Natalie,
Gerlo Sarah,
Gevaert Philippe,
Vandekerckhove Linos
Publication year - 2022
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.15101
Subject(s) - vaccination , covid-19 , virology , antibody , medicine , pandemic , neutralizing antibody , immunology , antibody response , outbreak , infectious disease (medical specialty) , disease , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom